OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
April 02, 2015
Quality-by-design tools improve efficiency in scale-up of pharmaceutical processes.
In-silico design facilitates process optimization and evaluation of process control strategies.
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.
A drug-product manufacturing classification system (MCS) for oral solid-dosage forms is proposed by an Academy of Pharmaceutical Sciences working group.
In this article, industry experts discuss critical analyses for demonstrating biosimilarity.
FDA approves a biosimilar and loses a commissioner in March.
Multivariate data analysis (MVDA) is being used to effectively handle complex datasets generated by process analytical technology (PAT) in biopharmaceutical process development and manufacturing.
March 31, 2015
Merck Serono announces that it will work with Intrexon to develop a cancer therapy using chimeric antigen receptor T-cells.
March 30, 2015
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.